FrancophonIA/ELRC3.0 huggingface dataset:
English: This compared with 5.1 to 5.6 mmHg in those using brinzolamide and 5.7 to 6.9 mmHg in those using timolol.
Slovenian: V primerjavi s tem se je očesni tlak pri bolnikih, ki so uporabljali brinzolamid, zmanjšal za 5,1 do 5,6 mmHg, medtem ko se je pri bolnikih, ki so uporabljali timolol, zmanjšal za 5,7 do 6,9 mmHg.
English: Why has Azarga been approved?
Slovenian: Zakaj je bilo zdravilo Azarga odobreno?
English: The second was a 12-month study comparing Azarga with the combination of timolol and dorzolamide (another carbonic anhydrase inhibitor) in 437 patients.
Slovenian: V drugi študiji, ki je trajala 12 mesecev, so zdravilo Azarga pri 437 bolnikih primerjali s kombinacijo timolola in dorzolamida (drugega zaviralca karboanhidraze).
English: For the full list of all side effects reported with Azarga, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Azarga, glejte navodilo za uporabo.
English: Azarga is a medicine that contains two active substances, brinzolamide and timolol.
Slovenian: Azarga je zdravilo, ki vsebuje dve zdravilni učinkovini, brinzolamid in timolol.
English: Bicarbonate is required for the production of the aqueous humour.
Slovenian: Bikarbonat je potreben pri tvorbi prekatne vodke.
English: In the second study, IOP had fallen from around 26 mmHg by around 8.3 mmHg after six months in both groups of patients.
Slovenian: V drugi študiji se je očesni tlak po šestih mesecih zdravljenja pri obeh skupinah bolnikov z izhodiščnih 26 mmHg zmanjšal za okoli 8,3 mmHg.
English: The first was a six-month study comparing Azarga with brinzolamide and with timolol used on their own in 523 patients.
Slovenian: V prvi študiji, ki je trajala šest mesecev, so zdravilo Azarga pri 523 bolnikih primerjali z brinzolamidom in timololom, ki so ju uporabili kot samostojni zdravili.
English: In the first study, IOP fell from around 21 mmHg by 8.0 to 8.7 mmHg in the patients using Azarga.
Slovenian: V prvi študiji se je očesni tlak pri bolnikih, ki so uporabljali zdravilo Azarga, z izhodiščnih 21 mmHg znižal za 8,0 do 8,7 mmHg.
English: Azarga is given as one drop into the affected eye(s) twice a day.
Slovenian: Odmerek zdravila Azarga je ena kapljica v prizadeto oko (očesi) dvakrat na dan. Suspenzijo je treba pred uporabo dobro pretresti.
English: Azarga contains two active substances, brinzolamide and timolol.
Slovenian: Zdravilo Azarga vsebuje dve zdravilni učinkovini, brinzolamid in timolol.
English: What is Azarga used for?
Slovenian: Za kaj se zdravilo Azarga uporablja?
English: How has Azarga been studied?
Slovenian: Kako je bilo zdravilo Azarga raziskano?
English: How does Azarga work?
Slovenian: Kako zdravilo Azarga deluje?
English: What is Azarga?
Slovenian: Kaj je zdravilo Azarga?
English: How is Azarga used?
Slovenian: Kako se zdravilo Azarga uporablja?
English: This summary was last updated in 12-2008.
Slovenian: Povzetek je bil nazadnje posodobljen 12-2008.
English: This medicine is the same as Insuman, which is already authorised in the European Union (EU).
Slovenian: To zdravilo je enako zdravilu Insuman, ki je že odobreno v Evropski uniji (EU).
English: The patient's blood glucose should be tested regularly to find the lowest effective dose.
Slovenian: Koncentracijo glukoze v krvi bolnika je treba redno testirati, da se tako določi najmanjši učinkoviti odmerek.
English: The European Commission granted a marketing authorisation valid throughout the EU for Insulin Human Winthrop to Sanofi-Aventis Deutschland GmbH on 17 January 2007.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Insulin Human Winthrop, veljavno po vsej Evropski uniji, odobrila družbi Sanofi-Aventis Deutschland GmbH dne 17. januarja 2007.
English: Insulin Human Winthrop has been studied in two trials in 611 patients with either type 1 diabetes (when the body cannot produce insulin) or type 2 diabetes (when the body is unable to use insulin effectively).
Slovenian: Zdravilo Insulin Human Winthrop so proučevali v okviru dveh študij s 611 bolniki s sladkorno boleznijo tipa 1 (kadar telo ne more tvoriti insulina) ali sladkorno boleznijo tipa 2 (kadar telo ne more učinkovito uporabljati insulina).
English: Insulin Human Winthrop Rapid may also be given into a vein, but only in hospital where the patient can be closely monitored.
Slovenian: Zdravilo Insulin Human Winthrop Rapid se lahko daje tudi v veno, vendar le v bolnišnici, kjer je mogoče bolnika natančno nadzorovati.
English: It is supplied in vials, cartridges, or pre-filled disposable pens (OptiSet and SoloStar).
Slovenian: Na voljo je v vialah, injekcijskih vložkih ali predhodno napolnjenih injekcijskih peresnikih za enkratno uporabo (OptiSet in SoloStar).
English: • Insulin Human Winthrop Comb 50: 50% soluble insulin and 50% crystalline protamine insulin.
Slovenian: • Insulin Human Winthrop Comb 50: 50 % topnega insulina in 50 % kristalnega protamin-insulina.
English: The studies measured the ‘fasting' blood glucose levels (measured when the patient had not eaten for at least eight hours), or the levels of a substance in the blood called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
Slovenian: V okviru študij so merili raven glukoze na tešče (izmerjeno, ko bolnik najmanj osem ur ni zaužil hrane) ali koncentracijo snovi, imenovane glikozilirani hemoglobin (HbA1c), ki kaže, kako dobro je glukoza v krvi uravnana.
English: The studies also looked at the number of patients who developed hypoglycaemia (low blood glucose levels).
Slovenian: V študijah so merili tudi število bolnikov, pri katerih se je pojavila hipoglikemija (nizka koncentracija glukoze v krvi).
English: The replacement insulin acts in the same way as naturally produced insulin and helps glucose enter cells from the blood.
Slovenian: Nadomestni insulin učinkuje na enak način kot naravno tvorjeni insulin ter omogoča vstop glukoze iz krvi v celice.
English: Diabetes is a disease in which the body does not produce enough insulin to control the level of blood glucose.
Slovenian: Sladkorna bolezen je bolezen, pri kateri telo ne proizvaja dovolj insulina za vzdrževanje primerne koncentracije glukoze v krvi.
English: Insulin Human Winthrop should not be used in people who may be hypersensitive (allergic) to insulin human or any of the other ingredients.
Slovenian: Zdravila Insulin Human Winthrop ne smejo uporabljati osebe, ki utegnejo biti preobčutljive za (alergične na) humani insulin ali katero koli drugo sestavino.
English: The active substance in Insulin Human Winthrop, insulin human, is produced by a method known as ‘recombinant DNA technology': it is made by a bacterium that has received a gene (DNA), which makes it able to produce insulin.
Slovenian: Zdravilno učinkovino v zdravilu Insulin Human Winthrop, humani insulin, proizvajajo z metodo, znano kot „tehnologija rekombinantne DNK“, pri kateri bakterija prejme gen (DNK), s katerim lahko tvori insulin.
English: Insulin Human Winthrop contains insulin in various forms: the soluble form, which acts quickly (within 30 minutes of injection), and the isophane and crystallineprotamine forms, which are absorbed much more slowly during the day, giving them a longer duration of action.
Slovenian: Zdravilo Insulin Human Winthrop vsebuje insulin v različnih oblikah: v topni obliki, ki učinkuje hitro (v 30 minutah po injiciranju), ter v izofan in kristalni obliki s protaminom, ki se absorbira veliko počasneje čez dan ter posledično zagotavlja daljše trajanje učinkovanja.
English: The Committee for Medicinal Products for Human Use (CHMP) decided that Insulin Human Winthrop's benefits are greater than its risks for the treatment of diabetes mellitus.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) je zaključil, da so koristi zdravila Insulin Human Winthrop pri zdravljenju sladkorne bolezni večje od z njim povezanih tveganj.
English: Insulin Human Winthrop should be given before meals.
Slovenian: Zdravilo Insulin Human Winthrop je treba dajati pred obrokom.
English: The company that makes Insuman has agreed that its scientific data can be used for Insulin Human Winthrop.
Slovenian: Družba, ki izdeluje zdravilo Insuman, se strinja, da se lahko znanstveni podatki o tem zdravilu uporabijo tudi za zdravilo Insulin Human Winthrop.
English: Insulin Human Winthrop doses might need to be adjusted when it is given with other medicines that may have an effect on blood glucose levels.
Slovenian: Odmerke zdravila Insulin Human Winthrop bo morda treba prilagoditi, če se zdravilo daje z drugimi zdravili, ki lahko vplivajo na koncentracije glukoze v krvi.
English: Insulin Human Winthrop Rapid can also be used for the treatment of hyperglycaemic coma (coma caused by too much blood glucose [sugar]) and ketoacidosis (high levels of ketones [acids] in the blood), and to control blood glucose before, during or after an operation.
Slovenian: Zdravilo Insulin Human Winthrop Rapid je primerno tudi za zdravljenje hiperglikemične kome (kome, ki jo povzroči previsoka koncentracija glukoze [sladkorja] v krvi) in ketoacidoze (visoke ravni ketonov [kislin] v krvi) ter za uravnavanje glukoze v krvi pred operacijo, med njo in po njej.
English: Insulin Human Winthrop is used in patients with diabetes who need treatment with insulin.
Slovenian: Zdravilo Insulin Human Winthrop se uporablja pri bolnikih s sladkorno boleznijo, ki potrebujejo zdravljenje z insulinom.
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) INSULIN HUMAN WINTHROP RAPID INSULIN HUMAN WINTHROP BASAL INSULIN HUMAN WINTHROP COMB (15, 25, 30, 50) INSULIN HUMAN WINTHROP INFUSAT EPAR summary for the public
Slovenian: INSULIN HUMAN WINTHROP RAPID INSULIN HUMAN WINTHROP BASAL INSULIN HUMAN WINTHROP COMB (15, 25, 30, 50) INSULIN HUMAN WINTHROP INFUSAT
English: Insulin Human Winthrop Infusat is specially prepared ready to be used in infusion pumps.
Slovenian: Zdravilo Insulin Human Winthrop Infusat je posebej pripravljeno za uporabo v infuzijskih črpalkah.
English: Insulin Human Winthrop was effective for both type 1 and type 2 diabetes.
Slovenian: Zdravilo Insulin Human Winthrop je bilo učinkovito pri sladkorni bolezni tipa 1 in tipa 2.
English: The Insulin Human Winthrop range is comprised of fast-acting insulin solutions (Insulin Human Winthrop Rapid and Insulin Human Winthrop Infusat) that contain soluble insulin, an intermediate-acting insulin suspension (Insulin Human Winthrop Basal) that contains isophane insulin, and combinations of fast- and intermediateacting in various proportions (Insulin Human Winthrop Comb):
Slovenian: Paleta izdelkov Insulin Human Winthrop vključuje raztopine insulinov s hitrim delovanjem (Insulin Human Winthrop Rapid in Insulin Human Winthrop Infusat), ki vsebujejo topni insulin, suspenzije insulinov s srednje dolgim delovanjem (Insulin Human Winthrop Basal), ki vsebujejo insulin izofan, ter kombinacije insulina s hitrim in srednje dolgim delovanjem v različnih razmerjih (Insulin Human Winthrop Comb):
English: The desired blood glucose levels, the type of Insulin Human Winthrop to be used, and the dose and timing of injections are determined by the doctor for each patient individually, and are adjusted to suit the patient's diet, physical activity and lifestyle.
Slovenian: Zdravnik za vsakega posameznika posebej določi zaželene koncentracije glukoze v krvi, vrsti zdravila Insulin Human Winthrop , ki ga je treba uporabiti, in čas uporabe injekcij ter jih prilagodi, da kar najbolje ustrezajo prehrani, telesni aktivnosti in življenjskemu slogu bolnika.
English: Other information about Insulin Human Winthrop:
Slovenian: Druge informacije o zdravilu Insulin Human Winthrop:
English: For the full list of all side effects reported with Insulin Human Winthrop, see the Package Leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Insulin Human Winthrop, glejte navodilo za uporabo.
English: In one of the studies, Insulin Human Winthrop was used in an insulin pump.
Slovenian: V eni od teh študij je bilo zdravilo Insulin Human Winthrop uporabljeno v insulinski črpalki.
English: Insulin Human Winthrop is given by injection under the skin, generally in the abdominal wall (tummy) or the thigh, according to the doctor's recommendations.
Slovenian: Zdravilo Insulin Human Winthrop se daje z injekcijo pod kožo, običajno v trebušno steno ali stegno v skladu s priporočilom zdravnika.
English: Insulin Human Winthrop led to a decrease in the level of HbA1c, indicating that blood glucose levels had been controlled to a similar level to that seen with semi-synthetic human insulin.
Slovenian: Zdravilo Insulin Human Winthrop je povzročilo znižanje koncentracije HbA1c, kar kaže, da so bile koncentracije glukoze v krvi vzdrževane na podobni ravni kot pri polsinteznem humanem insulinu.
English: Insulin Human Winthrop can cause hypoglycaemia.
Slovenian: Zdravilo Insulin Human Winthrop lahko povzroči hipoglikemijo.
English: In the other study, Insulin Human Winthrop Comb 25 was compared with semi-synthetic human insulin.
Slovenian: V drugi študiji pa so zdravilo Insulin Human Winthrop Comb 25 primerjali s polsinteznim humanim insulinom.
English: Insulin Human Winthrop is a replacement insulin that is identical to the insulin made by the body.
Slovenian: Zdravilo Insulin Human Winthrop je nadomestni insulin, ki je identičen insulinu, ki ga tvori telo.
English: The Committee recommended that Insulin Human Winthrop be given marketing authorisation.
Slovenian: Odbor je priporočil, da se za zdravilo Insulin Human Winthrop odobri dovoljenje za promet.
English: What benefit has Insulin Human Winthrop shown during the studies?
Slovenian: Kakšne koristi je zdravilo Insulin Human Winthrop izkazalo med študijami?
English: The full EPAR for Insulin Human Winthrop is available here.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Insulin Human Winthrop je na voljo tukaj.
English: Insulin Human Winthrop contains the active substance insulin human.
Slovenian: Zdravilo Insulin Human Winthrop vsebuje zdravilno učinkovino humani insulin.
English: Insulin Human Winthrop is a range of insulin solutions and suspensions for injection.
Slovenian: Zdravilo Insulin Human Winthrop obsega različne raztopine in suspenzije insulina za injiciranje.
English: Why has Insulin Human Winthrop been approved?
Slovenian: Zakaj je bilo zdravilo Insulin Human Winthrop odobreno?
English: What is the risk associated with Insulin Human Winthrop?
Slovenian: Kakšna tveganja so povezana z zdravilom Insulin Human Winthrop?
English: See the Package Leaflet for exact timings.
Slovenian: Natančen čas uporabe najdete v navodilu za uporabo.
English: How is Insulin Human Winthrop used?
Slovenian: Kako se Insulin Human Winthrop uporablja?
English: How has Insulin Human Winthrop been studied?
Slovenian: Kako je bilo zdravilo Insulin Human Winthrop raziskano?
English: What is Insulin Human Winthrop?
Slovenian: Kaj je zdravilo Insulin Human Winthrop?
English: What is Insulin Human Winthrop used for?
Slovenian: Za kaj se zdravilo Insulin Human Winthrop uporablja?
English: How does Insulin Human Winthrop work?
Slovenian: Kako zdravilo Insulin Human Winthrop deluje?
English: The safety profile of the medicine is considered acceptable.
Slovenian: Varnostni profil zdravila je ocenjen kot sprejemljiv.
English: As a result, it prevents the growth of tumour cells and eventually kills them.
Slovenian: Tako preprečuje rast tumorskih celic in jih sčasoma uniči.
English: Further information on Xeloda can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/Xeloda.
Slovenian: Nadaljnje informacije za zdravilo Xeloda so na voljo na spletni strani agencije: ema.europa.eu/medicines/human/EPAR/Xeloda.
English: Xeloda is available as tablets (150 and 500 mg).
Slovenian: Na voljo je v obliki tablet (150 in 500 mg).
English: The European Medicines Agency therefore decided that Xeloda's benefits are greater than its risks and it can be authorised for use in the EU.
Slovenian: Evropska agencija za zdravila je zato zaključila, da so koristi zdravila Xeloda večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
English: The tablets are given twice daily for 14 days followed by a 7-day gap before the next course.
Slovenian: Jemljejo se 14 dni dvakrat na dan, čemur sledi enotedenski premor pred naslednjim ciklom.
English: Fluorouracil is very similar to pyrimidine.
Slovenian: Fluorouracil je zelo podoben pirimidinu.
English: What measures are being taken to ensure the safe and effective use of Xeloda?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Xeloda?
English: • pregnant or breastfeeding women;
Slovenian: • nosečnicah ali ženskah, ki dojijo;
English: Xeloda received a marketing authorisation valid throughout the EU on 2 February 2001.
Slovenian: Za zdravilo Xeloda je bilo 2. februarja 2001 izdano dovoljenje za promet, veljavno po vsej Evropski uniji.
English: For other types of cancer, treatment is stopped if the disease gets worse or the side effects are unacceptable.
Slovenian: Pri drugih oblikah raka je treba zdravljenje prekiniti, če se bolezen poslabša ali so neželeni učinki nesprejemljivi.
English: Xeloda tablets should be taken within 30 minutes after a meal.
Slovenian: Tablete zdravila Xeloda je treba vzeti z vodo v 30 minutah po obroku.
English: The disease responded in 19 to 25% of patients treated with Xeloda, compared with 12 to 15% with the comparator combination.
Slovenian: Bolezen se je odzvala pri 19 do 25 % bolnikov, zdravljenih z zdravilom Xeloda, v primerjavi z 12 do 15 % bolnikov, ki so jemali primerjalno kombinacijo.
English: Other information about Xeloda
Slovenian: Druge informacije o zdravilu Xeloda
English: Treatment is continued for 6 months after colon surgery.
Slovenian: Zdravljenje se nadaljuje šest mesecev po operaciji debelega črevesa.
English: As for all medicines, data on the use of Xeloda are continuously monitored.
Slovenian: Tako kot za vsako zdravilo se tudi podatki o uporabi zdravila Xeloda stalno spremljajo.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Xeloda have been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in previdnostni ukrepi, ki jih morajo za varno in učinkovito uporabo zdravila Xeloda upoštevati zdravstveni delavci in bolniki, so vključeni v povzetek glavnih značilnosti zdravila in navodilo za uporabo.
English: The most common side effects with Xeloda are diarrhoea, nausea (feeling sick), vomiting, abdominal (belly) pain, stomatitis (sores in the mouth), palmar-plantar erythrodysaesthesia (hand-foot syndrome, a skin reaction with rash and pain on the hands and feet), tiredness, weakness, loss of appetite, problems due to formation of blood clots in the blood vessels, heart problems and kidney problems in patients who already have reduced kidney function.
Slovenian: Najpogostejši neželeni učinki zdravila Xeloda so driska, navzeja (siljenje na bruhanje), bruhanje, bolečina v trebuhu, stomatitis (razjede v ustih), palmarno-plantarna eritrodisestezija (sindrom rokanoga, kožne reakcije z izpuščaji in bolečinami v rokah in nogah), utrujenost, šibkost, izguba teka, težave zaradi nastajanja krvnih strdkov v krvnih žilah, težave s srcem in ledvicami pri bolnikih, ki so že imeli okvaro delovanja ledvic.
English: Side effects reported with Xeloda are carefully evaluated and any necessary action taken to protect patients.
Slovenian: Neželeni učinki, o katerih so poročali pri zdravilu Xeloda, se skrbno ovrednotijo in po potrebi se sprejmejo ukrepi za zaščito bolnikov.
English: • patients taking brivudine (an antiviral medicine for treating shingles or chickenpox) or who have taken it in the last 4 weeks.
Slovenian: • bolnikih, ki jemljejo brivudin (protivirusno zdravilo za zdravljenje pasovca ali noric) ali ki so ga prejeli v zadnjih štirih tednih.
English: Xeloda is taken as tablets, while fluorouracil normally needs to be injected.
Slovenian: Zdravilo Xeloda se jemlje v obliki tablet, medtem ko je treba fluorouracil navadno injicirati.
English: What benefits of Xeloda have been shown in studies?
Slovenian: Kakšne koristi zdravila Xeloda so se pokazale v študijah?
English: • patients with severe leucopenia, neutropenia, or thrombocytopenia (low levels of white cells or platelets in the blood);
Slovenian: • bolnikih s hudo levkopenijo, nevtropenijo ali trombocitopenijo (nizkimi ravnmi belih krvnih celic ali trombocitov v krvi);
English: An overview of Xeloda and why it is authorised in the EU
Slovenian: Pregled zdravila Xeloda in zakaj je odobreno v EU
English: For more information about using Xeloda, see the package leaflet or contact your doctor or pharmacist.
Slovenian: Za več informacij glede uporabe zdravila Xeloda glejte navodilo za uporabo ali se posvetujte z zdravnikom ali farmacevtom.
English: Why is Xeloda authorised in the EU?
Slovenian: Zakaj je bilo zdravilo Xeloda odobreno v EU?
English: • patients who have had severe and unexpected reactions to fluoropyrimidine therapy;
Slovenian: • bolnikih, ki so imeli hudo in nepričakovano reakcijo na zdravljenje s fluoropirimidinom;
English: About two-thirds of the patients taking Xeloda or the combination remained disease-free throughout the 3.8 years of the study.
Slovenian: Približno dve tretjini bolnikov, ki so jemali zdravilo Xeloda ali kombinacijo, v vseh 3,8 letih študije ni kazalo znakov bolezni.
English: • locally advanced or metastatic breast cancer (breast cancer that has begun to spread to other parts of the body).
Slovenian: • lokalno napredovalega ali metastatskega raka dojk (ki se je začel širiti na druge dele telesa).
English: It can also be used on its own when treatment with both anthracyclines and taxanes (another type of cancer medicine) has failed or when further treatment with anthracyclines is not suitable for the patient.
Slovenian: Lahko se uporablja tudi samostojno, če je bilo zdravljenje z antraciklini in taksani (drugimi vrstami zdravil za zdravljenje raka) neuspešno ali če nadaljnje zdravljenje z antraciklini za bolnika ni primerno.
English: In the body, fluorouracil takes the place of pyrimidine and interferes with the enzymes involved in making new DNA.
Slovenian: Fluorouracil v telesu zavzame mesto pirimidina in ovira encime, ki sodelujejo pri tvorjenju nove DNK.
English: What are the risks associated with Xeloda?
Slovenian: Kakšna tveganja so povezana z zdravilom Xeloda?
English: Xeloda is a cancer medicine that is used to treat:
Slovenian: Xeloda je zdravilo za zdravljenje raka, ki se uporablja za zdravljenje:
English: What is Xeloda and what is it used for?
Slovenian: Kaj je zdravilo Xeloda in za kaj se uporablja?
English: Xeloda must not be used in people who may be hypersensitive (allergic) to capecitabine, to any of the other ingredients, or to fluorouracil.
Slovenian: Zdravila Xeloda ne smejo uporabljati osebe, ki utegnejo biti preobčutljive za (alergične na) kapecitabin, katero koli drugo sestavino zdravila ali fluorouracil.
English: • patients with complete absence of activity of the dihydropyrimidine dehydrogenase enzyme;
Slovenian: • bolnikih s popolnim pomanjkanjem dejavnosti encima dihidropirimidin dehidrogenaze;
English: The dose depends on the patient's height and weight and the type of cancer being treated.
Slovenian: Odmerek je odvisen od bolnikove telesne višine in telesne mase ter vrste raka, ki se zdravi.
English: Two smaller studies (238 patients) showed that Xeloda was effective after treatment with taxanes and anthracyclines did not work.
Slovenian: Dve manjši študiji (238 bolnikov) sta pokazali, da je bilo zdravilo Xeloda učinkovito, kadar zdravljenje s taksani in antraciklini ni delovalo.
English: Xeloda should only be prescribed by a doctor who is experienced in the use of cancer medicines.
Slovenian: Zdravilo Xeloda lahko predpiše le zdravnik, ki ima izkušnje z uporabo zdravil za zdravljenje raka.
English: Xeloda has been shown to be effective in treating colon, colorectal, gastric and breast cancer.
Slovenian: Zdravilo Xeloda se je izkazalo za učinkovito pri zdravljenju raka debelega črevesa, kolorektalnega raka, raka želodca in raka dojk.